Literature DB >> 8398983

Germline transcripts of the murine immunoglobulin gamma 2a gene: structure and induction by IFN-gamma.

J T Collins1, W A Dunnick.   

Abstract

The switch in expression by B cells from IgM to IgG, IgE, or IgA is accomplished by a DNA deletion. The deletion event is regulated, in that specific cytokines direct the B cell to switch to one, or sometimes two, of the six possible murine heavy chain genes. Prior to switch recombination, cytokine treatment also induces the transcription of the constant, switch, and upstream regions of the targeted heavy chain. Much evidence indicates that IFN-gamma directs switch recombination to the murine gamma 2a gene. By developing probes specific for the gamma 2a gene, we demonstrate that IFN-gamma increases germline transcription of this gene in both normal B cells and in the 18.81.A20 pre-B lymphoma. We have obtained cloned copies of three different germline gamma 2a transcripts, each with a different donor splice site. We have also located the 5' ends of these transcripts. The vast majority of the germline gamma 2a transcripts have a long first exon (> 700 bp), consistent with observations by Severinson and her colleagues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398983     DOI: 10.1093/intimm/5.8.885

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  21 in total

1.  Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene.

Authors:  L Pan; S Sato; J P Frederick; X H Sun; Y Zhuang
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  T-bet regulates IgG class switching and pathogenic autoantibody production.

Authors:  Stanford L Peng; Susanne J Szabo; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

3.  Sex hormones modulate the immune response to Plasmodium berghei ANKA in CBA/Ca mice.

Authors:  Martha Legorreta-Herrera; Néstor Aarón Mosqueda-Romo; Karen Elizabeth Nava-Castro; Ana Laura Morales-Rodríguez; Fidel Orlando Buendía-González; Jorge Morales-Montor
Journal:  Parasitol Res       Date:  2015-04-16       Impact factor: 2.289

4.  Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.

Authors:  David A Savitsky; Hideyuki Yanai; Tomohiko Tamura; Tadatsugu Taniguchi; Kenya Honda
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

Review 5.  A transcriptional serenAID: the role of noncoding RNAs in class switch recombination.

Authors:  William T Yewdell; Jayanta Chaudhuri
Journal:  Int Immunol       Date:  2017-04-01       Impact factor: 4.823

6.  Robust immune response elicited by a novel and unique Mycobacterium tuberculosis protein using an optimized DNA/protein heterologous prime/boost protocol.

Authors:  Mark J Cayabyab; Suely S Kashino; Antonio Campos-Neto
Journal:  Immunology       Date:  2012-03       Impact factor: 7.397

7.  Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice.

Authors:  Jieh-Juen Yu; Tatareddy Goluguri; M Neal Guentzel; James P Chambers; Ashlesh K Murthy; Karl E Klose; Thomas G Forsthuber; Bernard P Arulanandam
Journal:  Clin Vaccine Immunol       Date:  2009-12-16

8.  Antibody isotype analysis of malaria-nematode co-infection: problems and solutions associated with cross-reactivity.

Authors:  Karen J Fairlie-Clarke; Tracey J Lamb; Jean Langhorne; Andrea L Graham; Judith E Allen
Journal:  BMC Immunol       Date:  2010-02-17       Impact factor: 3.615

9.  Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations.

Authors:  Suzanne M Bal; Zhi Ding; Gideon F A Kersten; Wim Jiskoot; Joke A Bouwstra
Journal:  Pharm Res       Date:  2010-06-18       Impact factor: 4.200

10.  Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen.

Authors:  Ishita Mandal-Ghosh; Utpala Chattopadhyay; Rathindranath Baral
Journal:  Cancer Immun       Date:  2007-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.